News

Public · Published

IonQ Swings To Q3 Profit; Raises FY26 Revenue Outlook

IonQ reported third-quarter net income of $563.96 million, reversing a loss a year earlier, while revenue rose 336% year over year to $173.8 million. A $896.2 million gain from changes in warrant liabilities contributed to net income, even as adjusted loss per share widened. IonQ raised its 2026 revenue outlook to $505 million–$515 million.

Published:

Updated:

What happened

IonQ reported third-quarter net income of $563.96 million, reversing a loss a year earlier, while revenue rose 336% year over year to $173.8 million. A $896.2 million gain from changes in warrant liabilities contributed to net income, even as adjusted loss per share widened. IonQ raised its 2026 revenue outlook to $505 million–$515 million.

Confirmed

Global impact / market context

The higher outlook signals management expects demand for quantum technologies to support more revenue, while the reported profit was heavily influenced by a warrant-related accounting gain. The wider adjusted loss indicates the quarter’s underlying results did not yet show improved profit on that measure.

Analyst inference

Revenue growth came across quantum computing, sensing and foundry services, with contributions from the SkyWater acquisition. That means the reported increase reflects both business growth and an acquired operation; the article does not separate how much each contributed or describe cash generation.

Analyst inference

What to watch

  1. Compare future revenue with the $505 million–$515 million 2026 outlook and assess whether growth continues across quantum computing, sensing and foundry services. Analyst inference
  2. Check whether adjusted loss per share narrows from $0.29; this measure excludes some accounting effects and offers a different view from reported net income. Analyst inference
  3. Look for further detail on SkyWater’s contribution to revenue, since the article says the acquisition contributed but does not quantify its share. Analyst inference

Evidence

  • Original source link unavailable